MedPath

Effect of recombinant HCG administration in infertile women with IVF procedure

Phase 3
Conditions
infertility.
Inability to achieve a pregnancy sterility
Registration Number
IRCT2015012020736N1
Lead Sponsor
Vice chancellor for research, Tehran University of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
250
Inclusion Criteria

Infertile women who were IVF candidate;
infertile women who was recipient of Freezing embryo;
Exclusion criteria:
having uterus fibroma;
having polyps bigger than 2 cm;
Having Mullerian anomaly;

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: after four weekes. Method of measurement: B-HCG , miliunit.
Secondary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: two weeks after intervention. Method of measurement: transvaginal ultrasound and FHR.
© Copyright 2025. All Rights Reserved by MedPath